Hellstrom-Lindberg E - Search Results

1

ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.

Beauchamp EM, Leventhal M, Bernard E, Hoppe ER, Todisco G, Creignou M, Gallì A, Castellano CA, McConkey M, Tarun A, Wong W, Schenone M, Stanclift C, Tanenbaum B, Malolepsza E, Nilsson B, Bick AG, Weinstock JS, Miller M, Niroula A, Dunford A, Taylor-Weiner A, Wood T, Barbera A, Anand S, Psaty BM, Desai P, Cho MH, Johnson AD, Loos R; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; MacArthur DG, Lek M; Exome Aggregation Consortium; Neuberg DS, Lage K, Carr SA, Hellstrom-Lindberg E, Malcovati L, Papaemmanuil E, Stewart C, Getz G, Bradley RK, Jaiswal S, Ebert BL. Beauchamp EM, et al. Blood Cancer Discov. 2021 Sep;2(5):500-517. doi: 10.1158/2643-3230.BCD-20-0224. Epub 2021 Jul 14. Blood Cancer Discov. 2021. PMID: 34568833 Free PMC article.

2

Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.

Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Nilsson L, et al. Blood. 2002 Jul 1;100(1):259-67. doi: 10.1182/blood-2001-12-0188. Blood. 2002. PMID: 12070035 Free article.

3

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.

Tehranchi R, Fadeel B, Forsblom AM, Christensson B, Samuelsson J, Zhivotovsky B, Hellstrom-Lindberg E. Tehranchi R, et al. Blood. 2003 Feb 1;101(3):1080-6. doi: 10.1182/blood-2002-06-1774. Epub 2002 Sep 5. Blood. 2003. PMID: 12393561 Free article.

4

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.

Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, Hellström-Lindberg E. Tehranchi R, et al. Blood. 2005 Jul 1;106(1):247-53. doi: 10.1182/blood-2004-12-4649. Epub 2005 Mar 8. Blood. 2005. PMID: 15755901 Free article.

5

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.

Nilsson L, Edén P, Olsson E, Månsson R, Astrand-Grundström I, Strömbeck B, Theilgaard-Mönch K, Anderson K, Hast R, Hellström-Lindberg E, Samuelsson J, Bergh G, Nerlov C, Johansson B, Sigvardsson M, Borg A, Jacobsen SE. Nilsson L, et al. Blood. 2007 Oct 15;110(8):3005-14. doi: 10.1182/blood-2007-03-079368. Epub 2007 Jul 6. Blood. 2007. PMID: 17616640 Free article.

6

Supportive care, growth factors, and new therapies in myelodysplastic syndromes.

Hellström-Lindberg E, Malcovati L. Hellström-Lindberg E, et al. Blood Rev. 2008 Mar;22(2):75-91. doi: 10.1016/j.blre.2007.10.003. Epub 2008 Feb 20. Blood Rev. 2008. PMID: 18068281 Review.

7

Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.

Hellström-Lindberg E, Malcovati L. Hellström-Lindberg E, et al. Semin Hematol. 2008 Jan;45(1):14-22. doi: 10.1053/j.seminhematol.2007.10.004. Semin Hematol. 2008. PMID: 18179965 Review.

8

Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome.

Jädersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, Pascutto C, Porwit A, Cazzola M, Hellström-Lindberg E. Jädersten M, et al. J Clin Oncol. 2008 Jul 20;26(21):3607-13. doi: 10.1200/JCO.2007.15.4906. Epub 2008 Jun 16. J Clin Oncol. 2008. PMID: 18559873

9

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Malcovati L, Della Porta MG, Pietra D, Boveri E, Pellagatti A, Gallì A, Travaglino E, Brisci A, Rumi E, Passamonti F, Invernizzi R, Cremonesi L, Boultwood J, Wainscoat JS, Hellström-Lindberg E, Cazzola M. Malcovati L, et al. Blood. 2009 Oct 22;114(17):3538-45. doi: 10.1182/blood-2009-05-222331. Epub 2009 Aug 19. Blood. 2009. PMID: 19692701 Free article.

10

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes.

Hellström-Lindberg E. Hellström-Lindberg E. Blood Rev. 2010 Mar;24(2):83-90. doi: 10.1016/j.blre.2010.01.002. Epub 2010 Feb 19. Blood Rev. 2010. PMID: 20171768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters